1. Home
  2. TMDX vs BXMT Comparison

TMDX vs BXMT Comparison

Compare TMDX & BXMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • BXMT
  • Stock Information
  • Founded
  • TMDX 1998
  • BXMT 1966
  • Country
  • TMDX United States
  • BXMT United States
  • Employees
  • TMDX N/A
  • BXMT N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • BXMT Real Estate Investment Trusts
  • Sector
  • TMDX Health Care
  • BXMT Real Estate
  • Exchange
  • TMDX Nasdaq
  • BXMT Nasdaq
  • Market Cap
  • TMDX 3.9B
  • BXMT 3.3B
  • IPO Year
  • TMDX 2019
  • BXMT N/A
  • Fundamental
  • Price
  • TMDX $107.79
  • BXMT $19.89
  • Analyst Decision
  • TMDX Buy
  • BXMT Hold
  • Analyst Count
  • TMDX 10
  • BXMT 6
  • Target Price
  • TMDX $122.11
  • BXMT $20.00
  • AVG Volume (30 Days)
  • TMDX 934.4K
  • BXMT 812.5K
  • Earning Date
  • TMDX 10-27-2025
  • BXMT 10-22-2025
  • Dividend Yield
  • TMDX N/A
  • BXMT 9.44%
  • EPS Growth
  • TMDX 2163.11
  • BXMT N/A
  • EPS
  • TMDX 2.02
  • BXMT N/A
  • Revenue
  • TMDX $531,292,000.00
  • BXMT $236,803,000.00
  • Revenue This Year
  • TMDX $38.86
  • BXMT N/A
  • Revenue Next Year
  • TMDX $20.79
  • BXMT $16.11
  • P/E Ratio
  • TMDX $53.44
  • BXMT N/A
  • Revenue Growth
  • TMDX 48.09
  • BXMT N/A
  • 52 Week Low
  • TMDX $55.00
  • BXMT $16.51
  • 52 Week High
  • TMDX $169.29
  • BXMT $21.24
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 39.83
  • BXMT 59.77
  • Support Level
  • TMDX $101.00
  • BXMT $19.79
  • Resistance Level
  • TMDX $117.96
  • BXMT $20.17
  • Average True Range (ATR)
  • TMDX 5.07
  • BXMT 0.30
  • MACD
  • TMDX -1.15
  • BXMT 0.08
  • Stochastic Oscillator
  • TMDX 31.08
  • BXMT 80.98

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About BXMT Blackstone Mortgage Trust Inc.

Blackstone Mortgage Trust Inc is a real estate finance company involved in the origination and purchase of senior loans collateralized by commercial properties in North America, Europe, and Australia. The vast majority of the company's asset portfolio is comprised of floating rate loans secured by priority mortgages. These mortgages are mainly derived from office, hotel, and manufactured housing properties. A percentage of the collateralized real estate properties are located in New York, California, and the United Kingdom. Blackstone Mortgage Trust is managed by a subsidiary of The Blackstone Group and benefits from the market data provided by its parent company. Nearly all of Blackstone Mortgage Trust's revenue is generated in the form of interest income.

Share on Social Networks: